always online......
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
For more information, visit www.lagunablends.com
The global wellness industry is a $3.4 trillion market. Defined as a state of complete physical, mental and social well-being, the topic of wellness is well worth delving into. Through its independent affiliates, LAGBF uses tools and technology to aid in building an international business from the comfort of one’s own home or literally anywhere in the world.
The Hemp Industries Associates (HIA) estimates that the total U.S. retail value of hemp products in 2012 was approximately $500 million – all of which includes food and body products, clothing, auto parts, building materials and other products. These figures are likely to fuel the aspiring network marketer to conclude that not only do they have the opportunity to work with an upward trending product, its versatility and appeal over a range of market sectors is more than apparent
Great....LAGBF.....Thanks.....
Laguna Introduces Pro369 Hemp Protein Beverage and Expands to Over 700 Independent Affiliates
KELOWNA, BC / ACCESSWIRE / April 4, 2016 / Laguna Blends Inc. (CSE: LAG) (OTC: LAGBF) (Frankfurt: LB6A.F) (the "Company" or "Laguna") is pleased to introduce "Pro369", Laguna's hemp protein, instant, functional beverage to its network of independent affiliates in the United States and Canada. Laguna's independent affiliates can purchase Pro369 as of 12:00pm PST today by accessing their Laguna affiliate shopping cart online.
Laguna has experienced rapid affiliate growth since its business launch on March 7, 2016. In less than a month Laguna has attracted more than 700 independent affiliates from all corners of the United States and Canada, which exceeds growth projections. Laguna intends on posting financial sales data in early May of 2016 to report its first seven weeks of sales.
The first product category that Laguna has introduced are unique, instant, functional beverage products that contain hemp protein, omegas, ginseng and other efficacious ingredients.
Naturally Splendid CEO Mr. Craig Goodwin states, "Laguna Blends is building a team of industry experts. We are excited to be a part of this team and look forward to providing Laguna Blends and their customers with a superior protein blend formulated with our HempOmega® technology. Laguna is the first Network Marketing Company to have access to this HempOmega® technology, which is a finalist for the prestigious NutraIngredients Awards in the category of Start-up Ingredient of the Year."
Stuart Gray, Laguna's President and CEO, said, "The feedback from the first product Laguna recently introduced, 'Caffe', has been tremendous. By infusing both hemp and whey with coffee we have generated interest in hemp within a mainstream market of coffee drinkers. We are equally as excited to now offer Pro369 to our active affiliates and their customers. Pro369 is a world-class product that contains hemp, omegas and ginseng. The Minister of Health from Health Canada has granted Laguna a product license along with a Natural Product Number ("NPN") for all four of the Pro369 Flavours. Notably, Laguna can make five health claims with just this product alone, putting Pro369 in a league of its own."
Naturally Splendid Enterprises Ltd. "Naturally Splendid" or "NSE" (FRANKFURT:50N) (TSX VENTURE:NSP) (OTC:NSPDF) provided the research and development of all four of the flavours of Pro369. In addition, Laguna and NSE have entered into a manufacturing agreement for Pro369.
About Laguna Blends Inc.
Laguna is a network marketing company that generates retail sales through independent affiliates. Affiliates utilize tools and technology that enable them to build an international business from their own home or anywhere else in the world. This technology replaces the need for expensive travel and hotel meetings.
The Company is currently focused on the nutritional health benefits derived from hemp. Laguna's first product category as an entry to market are functional beverage products that contain hemp and other efficacious ingredients. Laguna's initial products to market are the following:
"Caffe" is an instant, "just add water" hot coffee beverage that is infused with both whey and hemp protein. With 2 grams of protein in every serving, our proprietary product packs a powerful protein punch. Caffe, contains Instant coffee, whey protein hydrolysate, hemp protein, natural flavors.
"Pro369" is a single serving, "on-the-go," plant based, instant, hemp protein that is served cold and comes in 4 delicious flavors. Pro369 is water soluble and can be directly mixed in water, added to milk, almond milk or coconut milk. Pro369 can also be blended in a shake or smoothie. Pro369 is also a source of Omegas, 3, 6 and 9 and contains ginseng.
* By 2020 the global sports nutrition market should reach US$33.6 billion in revenues on the back of a 7 percent CAGR (compound annual growth rate), according to a new market report from Allied Market Research. For those living under a rock in recent years: the consumer demographic in the sports nutrition market has been expanding. While athletes account for about 37 percent of global sales of sports nutrition products and recreational users 27 percent, the market has witnessed emergence of a new user group dubbed as "lifestyle users." These new consumers tend to use sports nutrition products as beverages, meal replacements or healthy snacks, rather than purely for exercise-related nutrition. This group of lifestyle users will grow faster than any other in the sports nutrition market, followed by the recreational users, according to the report, which cited the rise in health club and fitness center locations worldwide as a key growth driver. Overall, the report predicted a greater adoption of sports nutrition products by working mothers, on-the-go business people and outdoor enthusiasts.
Laguna Blends has been granted approval from Health Canada for four powdered flavours: Pro369 Chocolate Banana, Mixed Berry and Vanilla Caramel and Tropical Powder. Pro369 contains Hemp protein, natural flavors, stevia, and American ginseng.
The Minister of Health from Health Canada has granted Laguna a product license along with a Natural Product Number ("NPN") for all four of the Pro369 Flavours. They are all listed under the same NPN.
i. A source of protein that helps build and repair body tissues.
ii. Source of amino acids involved in muscle protein synthesis.
iii. Assists in the building of lean muscle.
iv. An adaptogen to help maintain a healthy immune system.
v. Supportive therapy for the promotion of healthy glucose levels.
Hemp has long been recognized by the health and nutrition industry as a super food, cited in many publications as a balanced source of all ingredients required to achieve health and wellness.
HempOmega®
HempOmega® is an environmentally sustainable, vegetarian source of Omegas 3 and 6 that boasts a superior nutrient profile. A water soluble, homogenous, powdered ingredient, it can be easily integrated and/or manipulated, with no unpleasant taste or chemical contamination – opening up entirely new product formulation opportunities. Hemp Omega's greater ability to endure the digestive process delivers unmatched bioavailability, thereby maximizing its potential health benefits.
The Company sells its products through its independent affiliates in the USA and Canada.
HempOmega® is a Trademark owned by Naturally Splendid Enterprises, Ltd. and is used under license by Laguna Blends Inc.
* Natural Product Insider
http://www.naturalproductsinsider.com/
ON BEHALF OF THE BOARD
"Stuart Gray"
President, Chief Executive Officer,
FOR INVESTOR RELATIONS INFORMATION PLEASE CONTACT:
QualityStocks
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
ir@lagunablends.com
www.lagunablends.com
Join Us On Face Book: https://www.facebook.com/LagunaBlends/
Twitter: @LagunaBlends
Forward-Looking Information:
This news release contains "forward-looking information" within the meaning of applicable securities laws relating to statements regarding the Company's business, products and future plans including, without limitation, statements regarding use of proceeds, the expected launch date for the Company's business, its product offerings and plans for sales and marketing. Although the Company believes that the expectations reflected in the forward looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned to not place undue reliance on forward-looking information. Such forward looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Company's products and plan will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected. Except as required by law, the Company expressly disclaims any obligation, and does not intend, to update any forward looking statements or forward-looking information in this news release. The statements in this news release are made as of the date of this release.
SOURCE: Laguna Blends Inc.
Laguna Blends (PC) Company Description
Laguna Blends is a Network Marketing Company focused on the health, wellness and marketing of hemp based products. According to the Hemp Industries Association, retail sales of hemp food and body care products has grown from US$93 million in 2011 (an 8% increase year to year) to $186 million in 2014, an increase of 21.4% over the previous year. Larger growth is expected as legalization efforts at both the state and federal levels continue. In January of this year, the Industrial Hemp Farming Act of 2015 was introduced to Congress, which seeks to amend the Controlled Substance Act to exclude industrial hemp from the definition of marijuana. In Canada, sales in the sector amounted to CA$50 million and is forecasted to double in 2015 to $100 million. Products The initial products will focus on the nutritional and health-related benefits of the hemp seed. The first product category is in the functional beverage business. Current Products: "Caffe" is a whey- and hemp-infused water soluble coffee. The flavor and aroma of rich Arabica coffee with the mouth feel of hot chocolate. The first portable protein coffee. Pro369 - A combination of hemp protein, panax ginseng and micro-encapsulated hemp oil, with 13g of protein and 2.9g of Omegas 3,6 & 9. Easy to carry and combine in liquid or a smoothie. The first totally soluble protein powder. The combination of the two products gives you the protein and nutrition of a full meal-on-the-go. In Canada, the Pro369 is the first hemp protein powder to be registered with Health Canada as a Natural Product, with approved health claims: 1) A source of protein that helps build and repair body tissues. 2) Source of amino acids involved in muscle protein synthesis. 3) Assists in the building of lean muscle. 4) An adaptogen to help maintain a healthy immune system. 5) Supportive therapy for the promotion of healthy glucose levels. Planned expansion of the product categories may include cosmetics, and skin care, cannabinoids (CBDs), hemp oil as well as other product categories. In addition, Laguna will continue to expand its functional beverage line, including other coffee products. Marketing: The products will be sold via Independent Affiliates in a direct selling model. The Direct Selling Association reported that 18.2 million people were involved in the industry in 2014, with estimated retail sales of US$34.5 billion. One unique feature of the company strategy is to allow the independent Affiliates to expand their customer base without the need to travel for meetings and training, using a cutting edge, cloud based, immersive, 3D virtual World. Training and sales can be conducted on a 365/24/7 basis.
Laguna Expands from 135 Affiliates to 278 Affiliates in its First 6 Days Since Launching its Business
Print
Alert
KELOWNA, BC / ACCESSWIRE / March 14, 2016 / Laguna Blends Inc. (CSE: LAG) (Frankfurt: LB6A.F) (OTC: LAGBF) (the "Company" or "Laguna") launched sales on March 7th, 2016 with 135 Affiliates in the USA and Canada. As of Sunday March 13th, 2016, the number of Laguna's independent Affiliates across the USA and Canada had grown to 278, with an affiliate growth rate of 105%.
The first product category that Laguna has introduced are unique, instant, functional beverage products that contain hemp protein, omegas and other efficacious ingredients. The first product that is currently being offered for sale is "Caffe", Laguna's protein coffee beverage.
Stuart Gray, Laguna's President and CEO said, "Laguna has launched its business with a high level of interest from independent affiliates residing in the USA and Canada. The demand for high quality, functional beverage products throughout the United States and Canada, coupled with a viable business opportunity has attributed to the spike in affiliate interest. In addition, the positive feedback on Laguna’s first product to market, "Caffe" has been fantastic."
On March 3rd, 2016, Laguna announced that it had signed an LOI between Laguna and Robert Lamberton Consulting for the development of a "Limitless functional beverage Brain health and memory Coffee" product. Under the terms of the LOI all hard costs associated with the development of the brain health and memory coffee will be at Robert Lamberton Consulting's expense. Laguna and Robert Lamberton Consulting intend on entering into a formal R&D and development agreement outlining the details of the relationship before April 15, 2016.
The Company previously announced on March 2, 2016, that it is conducting a non-brokered private placement of up to 1,750,000 units at a price of $0.20 per unit for aggregate gross proceeds of up to $350,000. The Company has now closed the first tranche of this private placement consisting of 1,175,000 units for gross proceeds of $235,000. Each unit consists of one common share and one share purchase warrant, each warrant entitling the holder to acquire one additional common share of the Company at a price of $0.25 per warrant share until March 10, 2018. The units have a hold period expiring on July 11, 2016.
About Laguna Blends Inc.
Laguna is a network marketing company that generates retail sales through independent affiliates. Affiliates utilize tools and technology that enable them to build an international business from their own home or while travelling. This technology replaces the need for expensive travel and hotel meetings.
The Company is currently focused on the nutritional health benefits derived from hemp. Laguna's first product category as an entry to market are functional beverage products that contain hemp and other efficacious ingredients. Laguna's initial products to market are the following:
"Caffe" is an instant, "just add water" hot coffee beverage that is infused with both whey and hemp protein. With 20% protein (2 grams) in every serving, our proprietary product packs a powerful protein punch. Caffe, contains Instant coffee, whey protein hydrolysate, hemp protein, natural flavors.
Starbucks is the only company in the world that's a major player with a protein coffee beverage. Starbucks product is a ready to serve cold protein Coffee in a can. Laguna's protein Coffee is an instant, just add hot water protein coffee.
After water, the beverage that the largest proportion of adults reported consuming is Coffee. *According to the CAC's newly released 2013 Canadian Coffee Drinking Study, coffee is a dominant beverage in the Canadian market. Only tap water enjoys equally high past-day penetration. The results of the research show that approximately two-thirds of adult Canadians (65%) consumed coffee in the past-day. Approximately three-quarters of Canadians aged 18-79 (78%) indicate they've consumed coffee in the past week. A total of 83% of Canadians say they've enjoyed coffee in the past-year. Coffee drinkers consume on average 3.2 cups of coffee per day. A cup of coffee before you exercise can boost performance, help you stay hydrated and reduce exercise related fatigue as well as deliver a number of other positive health impacts.
"Pro369" is a single serving, "on-the-go," plant based, hemp protein that is served cold and comes in 4 delicious flavors. Pro369 is water soluble and can be directly mixed in water, added to milk, almond milk or coconut milk. Pro369 can also be blended in a shake or smoothie. Pro369 is also a source of Omegas, 3, 6 and 9 and contains ginseng.
Laguna Blends has been granted approval from Health Canada for four powdered flavours: PRO369 Chocolate Banana, Mixed Berry and Vanilla Caramel and Tropical Powder.
Pro369, contains Hemp protein, natural flavors, stevia, American ginseng.
The Minister of Health from Health Canada has granted Laguna a product license along with a Natural Product Number ("NPN") for all four of the Pro369 Flavours. They are all listed under the same NPN.
i. A source of protein that helps build and repair body tissues.
ii. Source of amino acids involved in muscle protein synthesis.
iii. Assists in the building of lean muscle.
iv. An adaptogen to help maintain a healthy immune system.
v. Supportive therapy for the promotion of healthy glucose levels.
Hemp has long been recognized by the health and nutrition industry as a super food, cited in many publications as a balanced source of all ingredients required to achieve health and wellness.
HempOmega®
HempOmega® is an environmentally sustainable, vegetarian source of Omegas 3 and 6 that boasts a superior nutrient profile. A water soluble, homogenous, powdered ingredient, it can be easily integrated and/or manipulated, with no unpleasant taste or chemical contamination – opening up entirely new product formulation opportunities. Hemp Omega's greater ability to endure the digestive process delivers unmatched bioavailability, thereby maximizing its potential health benefits.
The Company sells its products through its independent affiliates in the USA and Canada.
HempOmega® is a Trademark owned by Naturally Splendid Enterprises, Ltd. and is used under license by Laguna Blends Inc.
*Canadian Coffee Drinking Study
http://www.coffeeassoc.com/contact-us/
ON BEHALF OF THE BOARD
"Stuart Gray"
President, Chief Executive Officer,
Chief Financial Officer and Director
FOR INVESTOR RELATIONS INFORMATION PLEASE CONTACT:
Investor Relations
Glenn Shand / Stuart Gray
1-949-424-2716 Ext 2
ir@lagunablends.com
www.lagunablends.com
Join Us On Face Book: https://www.facebook.com/LagunaBlends/
Twitter: @LagunaBlends
Forward-Looking Information:
This news release contains "forward-looking information" within the meaning of applicable securities laws relating to statements regarding the Company's business, products and future plans including, without limitation, statements regarding use of proceeds, the expected launch date for the Company’s business, its product offerings and plans for sales and marketing. Although the Company believes that the expectations reflected in the forward looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned to not place undue reliance on forward-looking information. Such forward looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Company's products and plan will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected. Except as required by law, the Company expressly disclaims any obligation, and does not intend, to update any forward looking statements or forward-looking information in this news release. The statements in this news release are made as of the date of this release.
SOURCE: Laguna Blends Inc.
05/06/16-Cannabis Science CEO Launches Raymond C. Dabney University (RCDU) and Releases Schematics for Approx. 40 Acres (1.5 Million Sq. Ft.) With the McDermitt Indian Reservation for the Nevada Drug Development Complex
LOS ANGELES, CA -- (Marketwired) -- 05/06/16 -- Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is proud to unveil schematics for its first drug development complex. Cannabis Science CEO releases Raymond C. Dabney University out of California, which is the cornerstone of the Nevada Drug Development Complex. The complete property development deal is approximately 40 acres, spanning more than 1.5 million square feet located in McDermitt, Nevada.
The 40-acre community development project is based on a deal signed by RCDU, AEIG legal group and CBIS with the McDermitt Indian Reservation to develop land. The focal point of the community development project is the Raymond C. Dabney University, a fully accredited school of Law, Business, and Medicine. The Goal of Raymond C. Dabney University (RCDU) is to "provide financially challenged communities an affordable opportunity to acquire a quality legal education beginning with a structured and regulated program in Law."
"This whole experience has been a serious eye opening look into the future, launching the University, planning with Chief Bill, working with our outstanding legal group, and of course my team at Cannabis Science. We have now certainly made it to the next level and are growing much faster than we initially anticipated. The business model we have created with the McDermitt Tribe is something of a wonder when you do the math: let's just say potentially seeing over $10-20 million per month running through the system is what I'd call a serious economic stimulus package for all of us. The most compelling things are the jobs we are creating, the education we are providing, and the sense of hope for individuals like me who have never had this type of educational or job opportunity given to them for whatever reason. To be clear, this is the first of many hybrid University Medical complex communities we will be building. As time and resources permit, we will be offering University package courses in major cities across the United States and other countries, including but not limited to Canada, Europe, Africa, and Asia," stated Cannabis Science, Inc. President & CEO, Co-Founder, Mr. Raymond C. Dabney.
Please visit www.rcdu.com for an initial run down of Law course curriculum and tuition fees. The initial Mission of Raymond C. Dabney University is to provide to working adults of the community an affordable opportunity to acquire a quality legal education within a structured and regulated program in law leading to the degree of Juris Doctor.
RCDU will be providing free scholarships and additionally subsidized education packages for the Tribe Members of the Community. In exchange for and in addition to the land, the tribe will provide RCDU with a University building, lab space, and medical clinic facilities. The intent is to create a self-sustaining community of academia, which allows business opportunities, medical advancement, and legal progress to thrive.
RCDU and its legal group will work closely with Cannabis Science and the McDermitt Tribe to manage and operate the University and Medical Complex. With approximately 40 acres to work with, it is designed to be a completely vertically integrated operations model providing hundreds of jobs for the community, educational, medical, construction, as the list goes on, there will be plenty of jobs for all.
About Cannabis Science, Inc.
Cannabis Science, Inc., takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently, there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. Our initial focus is on skin cancers, HIV/AIDS, and neurological conditions. The Company is proceeding with the research and development of its proprietary drugs as a part of this initial focus: CS-S/BCC-1, CS-TATI-1, and CS-NEURO-1, respectively.
Forward-Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as "anticipate," "seek," intend," "believe," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements. Safe Harbor Statement. The Private Securities Litigation Reform Act of 1995 provides a 'safe harbor' for forward-looking statements. Certain of the statements contained herein, which are not historical facts are forward looking statements with respect to events, the occurrence of which involved risks and uncertainties. These forward-looking statements may be impacted, either positively or negatively, by various factors. Information concerning potential factors that could affect the company are detailed from time to time in the company's reports filed with the Securities and Exchange Commission.
Cannabis Science, Inc.
Investor Relations
Teresa Misenheimer
teresa@cannabisscience.com
Tel: 1-888-263-0832
Cannabis Science, Inc.
Mr. Raymond C. Dabney
President & CEO, Co-Founder
raymond.dabney@cannabisscience.com
Tel: 1-888-263-0832
Cannabis Science, Inc.
Mr. Robert Kane
Director & CFO
info@cannabisscience.com
Tel: 1-888-263-0832
Source: Cannabis Science, Inc.
Annual Report CBIS (10-k) Date : 05/09/2016 @ 9:24PM
http://ih.advfn.com/p.php?pid=nmona&article=71407981
Annual Report CBIS (10-k) Date : 05/09/2016 @ 9:24PM
http://ih.advfn.com/p.php?pid=nmona&article=71407981
News out 05/09/16:CBIS Gets Set to Break Ground on Its 360,000 sq. ft. Ft. McDermitt Drug Development Project; Chief William Bills of the Fort McDermitt Tribal Allotment Indian Lands Tours Property With Investors/Licensees With 1 Million sq. ft. of Cultivation Licenses
Ft. McDermitt Allotment Allottees Lands, Which Is on the Ft. McDermitt Tribal Reservation, the Project Will Benefit Both Ft. McDermitt Tribe Members and Allotment Allottees
LOS ANGELES, CA -- (Marketwired) -- 05/09/16 -- Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is getting ready to break ground on its 10 acre (360,000 sq. ft.) Ft. McDermitt Drug Development Project. Chief William Bills of the Fort McDermitt Tribal Allotment Indian Lands tours property with investors/licensees with 1 million sq. ft. of cultivation licenses available for a limited time. To date, 11 acres (396,000 sq. ft.) are signed for, and additionally, 20 acres (720,000 sq. ft.) are spoken for.
Chief William Bills of the Fort McDermitt Tribal Allotment Indian Lands confirmed, "We are moving much faster and stronger than we initially anticipated, and we are excited to break ground on our property with CBIS & RCDU. We believe the University educational component will be a key element that cements our success on this property and our other properties across America. Our international families have stressed a great interest in the combined University education/cultivation/revenue model for their community growth initiatives as well. We are following up to provide them with the same compelling opportunities to grow.
"Our initial signing with Raymond and Roger has been a blessing and a great education for all of us. We are creating a hybrid business model through the University for many to benefit from for years to come on the Ft. McDermitt Allotment Allottees lands, which is on the Ft. McDermitt Tribal Reservation; the Project will benefit both Ft. McDermitt Tribe Members and Allotment Allottees. Our sovereign licenses are formatted just like Nevada/California State licenses providing a comfort zone of legal accountability and responsibility. Our major advantage over any other city is that 'we will have no waiting periods for the license approvals' such as other cities, which could be 90 days or 6 months with 'no certainty' of receipt even after initial investments have been made. Once we approve the land/parcel deal, we approve the license at the same time, so all investments are made with peace of mind. Our protocols and procedures will be strict and coherent; all our licensees will comply accordingly to provide us with uniformity and continuity for ease of tracking and exponential growth.
"Our initial licensing fees ranging from $150,000 to $250,000 levels the playing field compared to a typical Pre-ICO, which is usually $500,000 to $750,000. On top of it, other cities and cannot provide nearly as much cultivation square feet ratio as our 36,000 sq. ft. per acre for each (greenhouse approved) cultivation center. Instead of charging rent or lease payments to the investor/licensee we have embraced a profit sharing model providing a much faster return on capital investments including operating expenses, insurance, and legal compliance."
About RDCU McDermitt
The 40-acre community development project is based on a deal signed by RCDU, AEIG legal group and CBIS with the McDermitt Indian Reservation to develop the land. The focal point of the community development project is the Raymond C. Dabney University, a fully accredited school of Law, Business, and Medicine. The Goal of Raymond C. Dabney University (RCDU) is to "provide financially challenged communities an affordable opportunity to acquire a quality legal education beginning with a structured and regulated program in Law." RCDU will be providing free scholarships and additionally subsidized education packages for the McDermitt Tribe Members of the Community. RCDU and its legal group will work closely with Cannabis Science and the McDermitt Tribe to manage and operate the University/Cultivation/Medical Complex. The intent is to create a self-sustaining community of academia, which allows business opportunities, medical advancement, and legal progress to thrive. With approximately 40 acres to work with it is designed to be a completely vertically integrated operations model providing hundreds of jobs for the community, education, medical, construction, as the list goes on, there will be plenty of jobs for all.
About Cannabis Science, Inc.
Cannabis Science, Inc., takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently, there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. Our initial focus is on skin cancers, HIV/AIDS, and neurological conditions. The Company is proceeding with the research and development of its proprietary drugs as a part of this initial focus: CS-S/BCC-1, CS-TATI-1, and CS-NEURO-1, respectively.
Forward-Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as "anticipate," "seek," intend," "believe," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc., does not undertake any duty nor does it intend to update the results of these forward-looking statements. Safe Harbor Statement. The Private Securities Litigation Reform Act of 1995 provides a 'safe harbor' for forward-looking statements. Certain of the statements contained herein, which are not historical facts are forward looking statements with respect to events, the occurrence of which involved risks and uncertainties. These forward-looking statements may be impacted, either positively or negatively, by various factors. Information concerning potential factors that could affect the company are detailed from time to time in the company's reports filed with the Securities and Exchange Commission.
Cannabis Science, Inc.
Investor Relations
Teresa Misenheimer
teresa@cannabisscience.com
Tel: 1-888-263-0832
Cannabis Science, Inc.
Mr. Raymond C. Dabney
President & CEO, Co-Founder
raymond.dabney@cannabisscience.com
Tel:1-888-263-0832
Cannabis Science, Inc.
Mr. Robert Kane
Director & CFO
info@cannabisscience.com
Tel: 1-888-263-0832
Source: Cannabis Science, Inc.
LOS ANGELES, CA--(Marketwired - May 6, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is proud to unveil schematics for its first drug development complex. Cannabis Science CEO releases Raymond C. Dabney University out of California, which is the cornerstone of the Nevada Drug Development Complex. The complete property development deal is approximately 40 acres, spanning more than 1.5 million square feet located in McDermitt, Nevada.
The 40-acre community development project is based on a deal signed by RCDU, AEIG legal group and CBIS with the McDermitt Indian Reservation to develop land. The focal point of the community development project is the Raymond C. Dabney University, a fully accredited school of Law, Business, and Medicine. The Goal of Raymond C. Dabney University (RCDU) is to "provide financially challenged communities an affordable opportunity to acquire a quality legal education beginning with a structured and regulated program in Law."
"This whole experience has been a serious eye opening look into the future, launching the University, planning with Chief Bill, working with our outstanding legal group, and of course my team at Cannabis Science. We have now certainly made it to the next level and are growing much faster than we initially anticipated. The business model we have created with the McDermitt Tribe is something of a wonder when you do the math: let's just say potentially seeing over $10-20 million per month running through the system is what I'd call a serious economic stimulus package for all of us. The most compelling things are the jobs we are creating, the education we are providing, and the sense of hope for individuals like me who have never had this type of educational or job opportunity given to them for whatever reason. To be clear, this is the first of many hybrid University Medical complex communities we will be building. As time and resources permit, we will be offering University package courses in major cities across the United States and other countries, including but not limited to Canada, Europe, Africa, and Asia," stated Cannabis Science, Inc. President & CEO, Co-Founder, Mr. Raymond C. Dabney.
Please visit www.rcdu.com for an initial run down of Law course curriculum and tuition fees. The initial Mission of Raymond C. Dabney University is to provide to working adults of the community an affordable opportunity to acquire a quality legal education within a structured and regulated program in law leading to the degree of Juris Doctor.
RCDU will be providing free scholarships and additionally subsidized education packages for the Tribe Members of the Community. In exchange for and in addition to the land, the tribe will provide RCDU with a University building, lab space, and medical clinic facilities. The intent is to create a self-sustaining community of academia, which allows business opportunities, medical advancement, and legal progress to thrive.
RCDU and its legal group will work closely with Cannabis Science and the McDermitt Tribe to manage and operate the University and Medical Complex. With approximately 40 acres to work with, it is designed to be a completely vertically integrated operations model providing hundreds of jobs for the community, educational, medical, construction, as the list goes on, there will be plenty of jobs for all.
About Cannabis Science, Inc.
Cannabis Science, Inc., takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently, there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. Our initial focus is on skin cancers, HIV/AIDS, and neurological conditions. The Company is proceeding with the research and development of its proprietary drugs as a part of this initial focus: CS-S/BCC-1, CS-TATI-1, and CS-NEURO-1, respectively.
Forward-Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as "anticipate," "seek," intend," "believe," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements. Safe Harbor Statement. The Private Securities Litigation Reform Act of 1995 provides a 'safe harbor' for forward-looking statements. Certain of the statements contained herein, which are not historical facts are forward looking statements with respect to events, the occurrence of which involved risks and uncertainties. These forward-looking statements may be impacted, either positively or negatively, by various factors. Information concerning potential factors that could affect the company are detailed from time to time in the company's reports filed with the Securities and Exchange Commission.
Cannabis Science, Inc.
Investor Relations
Teresa Misenheimer
teresa@cannabisscience.com
Tel: 1-888-263-0832
Cannabis Science, Inc.
Mr. Raymond C. Dabney
President & CEO, Co-Founder
raymond.dabney@cannabisscience.com
Tel: 1-888-263-0832
Cannabis Science, Inc.
Mr. Robert Kane
Director & CFO
info@cannabisscience.com
Tel: 1-888-263-0832
Thanks to OCKHAM'S RAZOR .....
"This whole experience has been a serious eye opening look into the future, launching the University, planning with Chief Bill, working with our outstanding legal group, and of course my team at Cannabis Science. We have now certainly made it to the next level and are growing much faster than we initially anticipated. The business model we have created with the McDermitt Tribe is something of a wonder when you do the math: let's just say potentially seeing over $10-20 million per month running through the system is what I'd call a serious economic stimulus package for all of us. The most compelling things are the jobs we are creating, the education we are providing, and the sense of hope for individuals like me who have never had this type of educational or job opportunity given to them for whatever reason. To be clear, this is the first of many hybrid University Medical complex communities we will be building. As time and resources permit, we will be offering University package courses in major cities across the United States and other countries, including but not limited to Canada, Europe, Africa, and Asia," stated Cannabis Science, Inc. President & CEO, Co-Founder, Mr. Raymond C. Dabney.
05/06/16-Cannabis Science CEO Launches Raymond C. Dabney University (RCDU) and Releases Schematics for Approx. 40 Acres (1.5 Million Sq. Ft.) With the McDermitt Indian Reservation for the Nevada Drug Development Complex
LOS ANGELES, CA -- (Marketwired) -- 05/06/16 -- Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is proud to unveil schematics for its first drug development complex. Cannabis Science CEO releases Raymond C. Dabney University out of California, which is the cornerstone of the Nevada Drug Development Complex. The complete property development deal is approximately 40 acres, spanning more than 1.5 million square feet located in McDermitt, Nevada.
The 40-acre community development project is based on a deal signed by RCDU, AEIG legal group and CBIS with the McDermitt Indian Reservation to develop land. The focal point of the community development project is the Raymond C. Dabney University, a fully accredited school of Law, Business, and Medicine. The Goal of Raymond C. Dabney University (RCDU) is to "provide financially challenged communities an affordable opportunity to acquire a quality legal education beginning with a structured and regulated program in Law."
"This whole experience has been a serious eye opening look into the future, launching the University, planning with Chief Bill, working with our outstanding legal group, and of course my team at Cannabis Science. We have now certainly made it to the next level and are growing much faster than we initially anticipated. The business model we have created with the McDermitt Tribe is something of a wonder when you do the math: let's just say potentially seeing over $10-20 million per month running through the system is what I'd call a serious economic stimulus package for all of us. The most compelling things are the jobs we are creating, the education we are providing, and the sense of hope for individuals like me who have never had this type of educational or job opportunity given to them for whatever reason. To be clear, this is the first of many hybrid University Medical complex communities we will be building. As time and resources permit, we will be offering University package courses in major cities across the United States and other countries, including but not limited to Canada, Europe, Africa, and Asia," stated Cannabis Science, Inc. President & CEO, Co-Founder, Mr. Raymond C. Dabney.
Please visit www.rcdu.com for an initial run down of Law course curriculum and tuition fees. The initial Mission of Raymond C. Dabney University is to provide to working adults of the community an affordable opportunity to acquire a quality legal education within a structured and regulated program in law leading to the degree of Juris Doctor.
RCDU will be providing free scholarships and additionally subsidized education packages for the Tribe Members of the Community. In exchange for and in addition to the land, the tribe will provide RCDU with a University building, lab space, and medical clinic facilities. The intent is to create a self-sustaining community of academia, which allows business opportunities, medical advancement, and legal progress to thrive.
RCDU and its legal group will work closely with Cannabis Science and the McDermitt Tribe to manage and operate the University and Medical Complex. With approximately 40 acres to work with, it is designed to be a completely vertically integrated operations model providing hundreds of jobs for the community, educational, medical, construction, as the list goes on, there will be plenty of jobs for all.
About Cannabis Science, Inc.
Cannabis Science, Inc., takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently, there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. Our initial focus is on skin cancers, HIV/AIDS, and neurological conditions. The Company is proceeding with the research and development of its proprietary drugs as a part of this initial focus: CS-S/BCC-1, CS-TATI-1, and CS-NEURO-1, respectively.
Forward-Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as "anticipate," "seek," intend," "believe," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements. Safe Harbor Statement. The Private Securities Litigation Reform Act of 1995 provides a 'safe harbor' for forward-looking statements. Certain of the statements contained herein, which are not historical facts are forward looking statements with respect to events, the occurrence of which involved risks and uncertainties. These forward-looking statements may be impacted, either positively or negatively, by various factors. Information concerning potential factors that could affect the company are detailed from time to time in the company's reports filed with the Securities and Exchange Commission.
Cannabis Science, Inc.
Investor Relations
Teresa Misenheimer
teresa@cannabisscience.com
Tel: 1-888-263-0832
Cannabis Science, Inc.
Mr. Raymond C. Dabney
President & CEO, Co-Founder
raymond.dabney@cannabisscience.com
Tel: 1-888-263-0832
Cannabis Science, Inc.
Mr. Robert Kane
Director & CFO
info@cannabisscience.com
Tel: 1-888-263-0832
Source: Cannabis Science, Inc.
The DEA green-lit a clinical trial of smoked marijuana for the treatment of post-traumatic stress disorder (PTSD) in American military veterans, a spokesperson for the government agency confirmed to Fortune. While other trials have studied the medical benefits of marijuana and cannabis extracts like cannabidiol, this is the first time regulators have allowed testing of the marijuana plant itself for the purpose of developing it into a legal medical drug.
...is pleased to publicly applaud the Drug Enforcement Agency (DEA) for their latest decision to green light clinical trials on the effectiveness of smoked marijuana as a treatment option for post-traumatic stress disorder, proposed Harborside resolution, and the re-scheduling for mass access to expanded treatments. These recent moves by the DEA seem to be signaling the signs of changing times, the right Industry at the right time.
05/04/16-Cannabis Science Rises to the Occasion, as the DEA Signals Signs of the Times; Approves Landmark Clinical Trial, Potential Harborside Resolution, and the DEA's Possible Decision to Re-Schedule Sooner Than We Think
COLORADO SPRINGS, CO -- (Marketwired) -- 05/04/16 -- Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to publicly applaud the Drug Enforcement Agency (DEA) for their latest decision to green light clinical trials on the effectiveness of smoked marijuana as a treatment option for post-traumatic stress disorder, proposed Harborside resolution, and the re-scheduling for mass access to expanded treatments. These recent moves by the DEA seem to be signaling the signs of changing times, the right Industry at the right time.
Cannabis Science believes this is it and the Company is very well positioned to move into mass expansion mode as new projects and current drug development initiatives get underway and move forward with exponential growth and sharply increased value.
Fortune Story on MAPS PTSD Study approved by the DEA:
The DEA green-lit a clinical trial of smoked marijuana for the treatment of post-traumatic stress disorder (PTSD) in American military veterans, a spokesperson for the government agency confirmed to Fortune. While other trials have studied the medical benefits of marijuana and cannabis extracts like cannabidiol, this is the first time regulators have allowed testing of the marijuana plant itself for the purpose of developing it into a legal medical drug.
The Multidisciplinary Association for Psychedelic Studies (MAPS), an organization researching legal uses for marijuana and other mind-altering drugs, is conducting the trial, which is funded by a $2.2 million grant from Colorado's state health department. MAPS had worked for more than five years to obtain clearance from regulators to use pot in the trial; while it received the OK from the U.S. Food and Drug Administration in 2011 and from the U.S. Public Health Service in 2014, it still had to wait for the DEA's approval in order to proceed.
http://fortune.com/2016/04/22/dea-medical-marijuana/?iid=sr-link1
Harborside story from the SFGATE:
In a milestone victory for the cannabis industry, the federal government agreed to drop its four-year bid to shut down Oakland's Harborside Health Center, the biggest medical marijuana dispensary in the country with more than 100,000 patients, city leaders said Tuesday.
The Department of Justice did not immediately comment on the deal, which Harborside said still needed to be finalized, with all of the parties in the legal fight signing off.
But Oakland officials joined the pot dispensary in an exultant news conference at City Hall, heralding a move they saw as symbolic of a federal withdrawal in the battle against an industry that is steadily marching toward acceptance -- and is viewed in Oakland not as a scourge but an economic engine.
"We celebrate the release from federal prosecution," said Mayor Libby Schaaf. "We believe in compassion, we believe in health."
http://www.sfgate.com/bayarea/article/Feds-drop-bid-to-shut-down-Harborside-in-big-win-7390365.php
The DEA has recently become more open to the benefits and plausibility of medical marijuana as a treatment option. In addition to green lighting this new trial, Harborside resolution, and of course with the agency recently announcing their intention to review the scheduling of marijuana as a drug within the first half of 2016. This is a great sign of progress for the agency.
"Can this be it? Will we see it sooner than later? We are so excited to be part of this industry as the federal government is starting to review antiquated policies, which have long acted as roadblocks to people seeking natural treatment options and Companies moving forward with viable treatment options for the people. I believe this is it. We are ready with all our formulations in place and new complex underway; we are certainly ready to rise to the occasion!" said Cannabis Science, Inc. CEO Raymond C. Dabney.
As federal and state policies loosen, companies like Cannabis Science will be able to perform studies, conduct trials, and roll out products much faster and more affordably. This progress is critical for companies to continue bringing more effective and affordable, natural treatments to patients across the country.
About Cannabis Science, Inc.
Cannabis Science, Inc., takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently, there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. Our initial focus is on skin cancers, HIV/AIDS, and neurological conditions. The Company is proceeding with the research and development of its proprietary drugs as a part of this initial focus: CS-S/BCC-1, CS-TATI-1, and CS-NEURO-1, respectively.
Forward-Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as "anticipate," "seek," intend," "believe," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc., does not undertake any duty nor does it intend to update the results of these forward-looking statements. Safe Harbor Statement. The Private Securities Litigation Reform Act of 1995 provides a 'safe harbor' for forward looking statements. Certain of the statements contained herein, which are not historical facts are forward looking statements with respect to events, the occurrence of which involved risks and uncertainties. These forward-looking statements may be impacted, either positively or negatively, by various factors. Information concerning potential factors that could affect the company are detailed from time to time in the company's reports filed with the Securities and Exchange Commission.
Cannabis Science, Inc.
Investor Relations
Teresa Misenheimer
teresa@cannabisscience.com
Tel: 1-888-263-0832
Cannabis Science, Inc.
Mr. Raymond C. Dabney
Director, President & CEO, Co-Founder
raymond.dabney@cannabisscience.com
Tel:1-888-263-0832
Cannabis Science, Inc.
Mr. Robert Kane
Director & CFO
info@cannabisscience.com
Tel: 1-888-263-0832
Source: Cannabis Science, Inc.